vorinostat has been researched along with Parasite Infections in 1 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
Excerpt | Relevance | Reference |
---|---|---|
"Vorinostat is a drug used to treat cutaneous T cell lymphoma whose action mechanism is based on Histone Deacetylase inhibition." | 2.66 | Vorinostat as potential antiparasitic drug. ( Ariza-Ortega, JA; Flores-García, Y; Herrera-Martínez, M; López-Contreras, L; Montaño, S; Orozco-Samperio, E, 2020) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Herrera-Martínez, M | 1 |
Orozco-Samperio, E | 1 |
Montaño, S | 1 |
Ariza-Ortega, JA | 1 |
Flores-García, Y | 1 |
López-Contreras, L | 1 |
1 review available for vorinostat and Parasite Infections
Article | Year |
---|---|
Vorinostat as potential antiparasitic drug.
Topics: Animals; Antiparasitic Agents; Drug Repositioning; Histone Deacetylase Inhibitors; Histone Deacetyla | 2020 |